Overview

Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This purpose of this phase 1 study is to investigate the safety and efficacy of erythropoetin for children with cerebral palsy.
Phase:
Phase 1
Details
Lead Sponsor:
MinYoung Kim, M.D.
Collaborator:
LG Life Sciences
Treatments:
Epoetin Alfa